5N7W image
Deposition Date 2017-02-21
Release Date 2018-11-14
Last Version Date 2024-11-06
Entry Detail
PDB ID:
5N7W
Keywords:
Title:
Computationally designed functional antibody
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
1.96 Å
R-Value Free:
0.24
R-Value Work:
0.19
R-Value Observed:
0.20
Space Group:
P 1 21 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Antibody Fragment Heavy Chain
Chain IDs:A, C (auth: H)
Chain Length:224
Number of Molecules:2
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:Antibody Fragment Light Chain
Chain IDs:B, D (auth: L)
Chain Length:214
Number of Molecules:2
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:Interleukin-17A
Gene (Uniprot):IL17A
Chain IDs:E (auth: X), F (auth: Y)
Chain Length:155
Number of Molecules:2
Biological Source:Homo sapiens
Primary Citation
Computational Design of Epitope-Specific Functional Antibodies.
Cell Rep 25 2121 2131.e5 (2018)
PMID: 30463010 DOI: 10.1016/j.celrep.2018.10.081

Abstact

The ultimate goal of protein design is to introduce new biological activity. We propose a computational approach for designing functional antibodies by focusing on functional epitopes, integrating large-scale statistical analysis with multiple structural models. Machine learning is used to analyze these models and predict specific residue-residue contacts. We use this approach to design a functional antibody to counter the proinflammatory effect of the cytokine interleukin-17A (IL-17A). X-ray crystallography confirms that the designed antibody binds the targeted epitope and the interaction is mediated by the designed contacts. Cell-based assays confirm that the antibody is functional. Importantly, this approach does not rely on a high-quality 3D model of the designed complex or even a solved structure of the target. As demonstrated here, this approach can be used to design biologically active antibodies, removing some of the main hurdles in antibody design and in drug discovery.

Legend

Protein

Chemical

Disease

Primary Citation of related structures